RIYADH — The Saudi Food and Drug Authority (SFDA) identified 17 pharmaceutical establishments in violation of regulations related to medicine availability and reporting, imposing fines totaling SR1.575 million. The violations were recorded during May, June and July 2026. According to the SFDA’s establishment compliance report, eight establishments failed to comply with requirements for directly reporting drug movements through the electronic Pharmaceutical Products Tracking System, “RSD.” The...